| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 3.09e-13 | 37 | 108 | 9 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 4.03e-13 | 38 | 108 | 9 | GO:0070001 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.59e-07 | 11 | 108 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 RHBDF1 ERVK-7 ERVK-21 ERVK-9 F7 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.15e-05 | 430 | 108 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | IgM binding | 2.46e-05 | 11 | 108 | 3 | GO:0001791 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 3.27e-05 | 12 | 108 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 4.66e-05 | 37 | 108 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.18e-05 | 38 | 108 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 RHBDF1 ERVK-7 ERVK-21 ERVK-9 PRPF8 F7 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 VCPIP1 | 5.25e-05 | 654 | 108 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 5.36e-05 | 14 | 108 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 6.91e-05 | 79 | 108 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 MAP1A EPB41L4B ERVK-7 ERVK-21 ERVK-9 MAGI2 HMCN1 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 ERVK-24 MYBPC1 | 8.93e-05 | 891 | 108 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.11e-04 | 46 | 108 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ENPP6 ERVK-6 PDE6C ERVK-7 H6PD PGAM5 SLFN13 SMPDL3A NYNRIN ERVK-8 CES3 PLCB2 PLCB3 ACP4 | 1.14e-04 | 807 | 108 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 1.18e-04 | 18 | 108 | 3 | GO:0032393 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.78e-04 | 152 | 108 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.83e-04 | 97 | 108 | 5 | GO:0008081 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.91e-04 | 21 | 108 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 2.87e-04 | 5 | 108 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 4.29e-04 | 6 | 108 | 2 | GO:0030109 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 5.98e-04 | 7 | 108 | 2 | GO:0023025 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 8.66e-04 | 136 | 108 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 8.66e-04 | 136 | 108 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 9.65e-04 | 36 | 108 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.61e-03 | 231 | 108 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 CAMKK1 AXL OAS3 ERVK-7 CAMKK2 TRNT1 TIE1 CIITA SPHK1 ERVK-8 POLD4 WEE2 | 1.65e-03 | 938 | 108 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.73e-03 | 507 | 108 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.73e-03 | 507 | 108 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.85e-03 | 12 | 108 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 3.31e-03 | 16 | 108 | 2 | GO:0023029 | |
| GeneOntologyMolecularFunction | ribosome binding | 4.11e-03 | 120 | 108 | 4 | GO:0043022 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 4.67e-03 | 19 | 108 | 2 | GO:0032394 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 5.02e-03 | 386 | 108 | 7 | GO:0042578 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.21e-03 | 599 | 108 | 9 | GO:0050839 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 MRC1 AXL LARP1 OAS3 ERVK-7 ERVK-21 ERVK-9 TRIM27 CIITA ERVK-8 ERVK-5 ERVK-19 ERVK-24 HCFC1 | 1.97e-08 | 464 | 108 | 15 | GO:0016032 |
| GeneOntologyBiologicalProcess | DNA integration | 4.90e-07 | 13 | 108 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 5.13e-06 | 48 | 108 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 1.15e-05 | 9 | 108 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | HFE LILRB3 LILRA2 AXL VSIG4 OAS3 TRIM27 LILRB1 GRAMD4 SVEP1 NF1 FBXO7 FCRLB | 2.61e-05 | 631 | 108 | 13 | GO:0002683 |
| GeneOntologyBiologicalProcess | cell-cell fusion | 8.43e-05 | 85 | 108 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 8.43e-05 | 85 | 108 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.05e-04 | 89 | 108 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 1.73e-04 | 21 | 108 | 3 | GO:0032926 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.13e-05 | 9 | 109 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 1.13e-05 | 9 | 109 | 3 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 2.93e-05 | 12 | 109 | 3 | GO:0032997 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 4.81e-05 | 14 | 109 | 3 | GO:0072379 | |
| Domain | Ig-like_fold | HFE PRTG LILRB3 LILRA2 TSPOAP1 AXL VSIG4 LILRA6 LILRB1 NOMO1 LRFN2 HMCN1 TIE1 NOMO2 FCRLB USH2A HCFC1 NOMO3 PLXNB1 VSTM1 MYBPC1 | 1.01e-10 | 706 | 99 | 21 | IPR013783 |
| Domain | - | HFE PRTG LILRA2 TSPOAP1 AXL VSIG4 LILRB1 NOMO1 LRFN2 HMCN1 TIE1 NOMO2 FCRLB USH2A HCFC1 NOMO3 PLXNB1 VSTM1 MYBPC1 | 1.65e-09 | 663 | 99 | 19 | 2.60.40.10 |
| Domain | IG | PRTG LILRB3 LILRA2 AXL VSIG4 LILRA6 LILRB1 LRFN2 HMCN1 TIE1 FCRLB VSTM1 MYBPC1 | 3.44e-07 | 421 | 99 | 13 | SM00409 |
| Domain | Ig_sub | PRTG LILRB3 LILRA2 AXL VSIG4 LILRA6 LILRB1 LRFN2 HMCN1 TIE1 FCRLB VSTM1 MYBPC1 | 3.44e-07 | 421 | 99 | 13 | IPR003599 |
| Domain | Ig-like_dom | HFE PRTG LILRB3 LILRA2 AXL VSIG4 LILRA6 LILRB1 LRFN2 HMCN1 TIE1 FCRLB VSTM1 MYBPC1 | 4.12e-07 | 503 | 99 | 14 | IPR007110 |
| Domain | DUF2012 | 5.76e-07 | 4 | 99 | 3 | PF09430 | |
| Domain | DUF2012 | 5.76e-07 | 4 | 99 | 3 | IPR019008 | |
| Domain | IG_LIKE | HFE PRTG LILRB3 LILRA2 AXL VSIG4 LILRA6 LILRB1 LRFN2 HMCN1 FCRLB VSTM1 MYBPC1 | 1.93e-06 | 491 | 99 | 13 | PS50835 |
| Domain | FN3 | 6.32e-06 | 185 | 99 | 8 | SM00060 | |
| Domain | ig | 7.69e-06 | 190 | 99 | 8 | PF00047 | |
| Domain | Immunoglobulin | 7.69e-06 | 190 | 99 | 8 | IPR013151 | |
| Domain | Carb-bd-like_fold | 7.94e-06 | 8 | 99 | 3 | IPR013784 | |
| Domain | FN3 | 1.08e-05 | 199 | 99 | 8 | PS50853 | |
| Domain | FN3_dom | 1.54e-05 | 209 | 99 | 8 | IPR003961 | |
| Domain | fn3 | 2.47e-05 | 162 | 99 | 7 | PF00041 | |
| Domain | CarboxyPept_regulatory_dom | 3.98e-05 | 13 | 99 | 3 | IPR014766 | |
| Domain | - | 3.98e-05 | 13 | 99 | 3 | 2.60.40.1120 | |
| Domain | PLC-beta_C | 8.32e-05 | 3 | 99 | 2 | IPR014815 | |
| Domain | PLC-beta_C | 8.32e-05 | 3 | 99 | 2 | PF08703 | |
| Domain | CarboxyPept-like_regulatory | 9.31e-05 | 17 | 99 | 3 | IPR008969 | |
| Domain | PLC-beta | 1.66e-04 | 4 | 99 | 2 | IPR016280 | |
| Domain | HoxA13_N | 1.66e-04 | 4 | 99 | 2 | PF12284 | |
| Domain | HoxA13_N | 1.66e-04 | 4 | 99 | 2 | IPR022067 | |
| Domain | IGc2 | 2.55e-04 | 235 | 99 | 7 | SM00408 | |
| Domain | Ig_sub2 | 2.55e-04 | 235 | 99 | 7 | IPR003598 | |
| Domain | Integrase_cat-core | 2.75e-04 | 5 | 99 | 2 | IPR001584 | |
| Domain | INTEGRASE | 2.75e-04 | 5 | 99 | 2 | PS50994 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 4.11e-04 | 6 | 99 | 2 | IPR016332 | |
| Domain | Ig_I-set | 5.24e-04 | 190 | 99 | 6 | IPR013098 | |
| Domain | I-set | 5.24e-04 | 190 | 99 | 6 | PF07679 | |
| Domain | Ig_2 | 6.11e-04 | 73 | 99 | 4 | PF13895 | |
| Domain | - | 1.48e-03 | 11 | 99 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 1.48e-03 | 11 | 99 | 2 | IPR023413 | |
| Domain | PLipase_C_Pinositol-sp_Y | 2.79e-03 | 15 | 99 | 2 | IPR001711 | |
| Domain | EF-hand_like | 2.79e-03 | 15 | 99 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 2.79e-03 | 15 | 99 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 2.79e-03 | 15 | 99 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 2.79e-03 | 15 | 99 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 2.79e-03 | 15 | 99 | 2 | PF00387 | |
| Domain | PLCYc | 2.79e-03 | 15 | 99 | 2 | SM00149 | |
| Domain | Retrov_capsid_C | 3.79e-03 | 59 | 99 | 3 | IPR008916 | |
| Domain | RasGAP_dom | 4.03e-03 | 18 | 99 | 2 | IPR001936 | |
| Domain | PI-PLC-X | 4.03e-03 | 18 | 99 | 2 | PF00388 | |
| Domain | PLCXc | 4.03e-03 | 18 | 99 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 4.48e-03 | 19 | 99 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 4.48e-03 | 19 | 99 | 2 | IPR000909 | |
| Domain | EGF | 4.54e-03 | 126 | 99 | 4 | PF00008 | |
| Domain | His_PPase_superfam | 4.97e-03 | 20 | 99 | 2 | IPR029033 | |
| Domain | - | 4.97e-03 | 20 | 99 | 2 | 3.40.50.1240 | |
| Domain | C2 | 5.21e-03 | 131 | 99 | 4 | PF00168 | |
| Domain | RNaseH-like_dom | 5.88e-03 | 69 | 99 | 3 | IPR012337 | |
| Domain | C2 | 6.09e-03 | 137 | 99 | 4 | SM00239 | |
| Domain | zf-CCHC | 6.54e-03 | 23 | 99 | 2 | PF00098 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 1.72e-05 | 11 | 68 | 3 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 1.72e-05 | 11 | 68 | 3 | MM15035 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.59e-05 | 39 | 68 | 4 | MM14496 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.31e-04 | 54 | 68 | 4 | M26911 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.27e-04 | 5 | 68 | 2 | MM14493 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 2.29e-04 | 25 | 68 | 3 | M39384 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 3.40e-04 | 6 | 68 | 2 | MM15662 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 3.40e-04 | 6 | 68 | 2 | M47548 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 3.77e-04 | 71 | 68 | 4 | MM14491 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 4.74e-04 | 7 | 68 | 2 | M47505 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 4.74e-04 | 7 | 68 | 2 | M27947 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 6.30e-04 | 8 | 68 | 2 | MM15032 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 6.30e-04 | 8 | 68 | 2 | M27356 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 6.30e-04 | 8 | 68 | 2 | M10546 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 6.30e-04 | 8 | 68 | 2 | MM15100 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 8.08e-04 | 9 | 68 | 2 | M3412 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 9.26e-04 | 90 | 68 | 4 | M6467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 1.01e-03 | 10 | 68 | 2 | M47644 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.01e-03 | 10 | 68 | 2 | M47661 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.01e-03 | 10 | 68 | 2 | M26910 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 1.01e-03 | 10 | 68 | 2 | M1825 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.12e-03 | 335 | 68 | 7 | MM14503 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 1.23e-03 | 11 | 68 | 2 | M47637 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.23e-03 | 11 | 68 | 2 | M49033 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.02e-13 | 5 | 111 | 5 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 ERVK-24 | 5.24e-13 | 94 | 111 | 10 | 21542922 |
| Pubmed | 2.35e-10 | 12 | 111 | 5 | 14557543 | ||
| Pubmed | 2.51e-09 | 18 | 111 | 5 | 18664271 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 36011023 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 10516026 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 3.16e-08 | 3 | 111 | 3 | 25576386 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.26e-07 | 4 | 111 | 3 | 31833031 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.26e-07 | 4 | 111 | 3 | 10469592 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 7983737 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 9267806 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 3.15e-07 | 5 | 111 | 3 | 11401426 | |
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 15063128 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 9079806 | ||
| Pubmed | 6.28e-07 | 6 | 111 | 3 | 30068593 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 17998301 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 30720883 | ||
| Pubmed | Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. | 1.10e-06 | 7 | 111 | 3 | 19658091 | |
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 9548455 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.75e-06 | 8 | 111 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.62e-06 | 9 | 111 | 3 | 36261522 | |
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 3.74e-06 | 10 | 111 | 3 | 18802077 | |
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 12970426 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 5.12e-06 | 11 | 111 | 3 | 32820719 | |
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 24052308 | ||
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 1.01e-05 | 2 | 111 | 2 | 36449053 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15242876 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 27151216 | ||
| Pubmed | The SphK1/S1P Axis Regulates Synaptic Vesicle Endocytosis via TRPC5 Channels. | 1.01e-05 | 2 | 111 | 2 | 37185099 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 12654522 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.01e-05 | 2 | 111 | 2 | 9460924 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17213473 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19617579 | ||
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 1.01e-05 | 2 | 111 | 2 | 33526815 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17015468 | ||
| Pubmed | Calcium/calmodulin kinase kinase beta has a male-specific role in memory formation. | 1.01e-05 | 2 | 111 | 2 | 17207577 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22334678 | ||
| Pubmed | Role of Ca(2+)/calmodulin-dependent protein kinase kinase in adrenal aldosterone production. | 1.01e-05 | 2 | 111 | 2 | 25679868 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 1.01e-05 | 2 | 111 | 2 | 11672541 | |
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 1.01e-05 | 2 | 111 | 2 | 24096970 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20631139 | ||
| Pubmed | DENND4A CAMKK1 LARP1 RAB11FIP1 TRIM27 PGAM5 ACSL3 NF1 NYNRIN | 1.38e-05 | 446 | 111 | 9 | 24255178 | |
| Pubmed | A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. | 1.40e-05 | 15 | 111 | 3 | 9144225 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.17e-05 | 361 | 111 | 8 | 30344098 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 17675482 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 12628440 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 28761320 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 18079968 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 9971820 | ||
| Pubmed | The relative role of PLCbeta and PI3Kgamma in platelet activation. | 3.02e-05 | 3 | 111 | 2 | 15705797 | |
| Pubmed | Regulation of phospholipase C-beta 3 activity by Na+/H+ exchanger regulatory factor 2. | 3.02e-05 | 3 | 111 | 2 | 10748023 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 19864584 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 14662864 | ||
| Pubmed | Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. | 3.02e-05 | 3 | 111 | 2 | 12529506 | |
| Pubmed | 4.04e-05 | 21 | 111 | 3 | 30270038 | ||
| Pubmed | Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells. | 6.03e-05 | 4 | 111 | 2 | 37338522 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9753089 | ||
| Pubmed | Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. | 6.03e-05 | 4 | 111 | 2 | 10669417 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 20502675 | ||
| Pubmed | Phospholipase C-β1 potentiates glucose-stimulated insulin secretion. | 6.03e-05 | 4 | 111 | 2 | 31268747 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9382880 | ||
| Pubmed | Selection of homeotic proteins for binding to a human DNA replication origin. | 6.03e-05 | 4 | 111 | 2 | 10835276 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 9188725 | ||
| Pubmed | TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway. | 6.03e-05 | 4 | 111 | 2 | 28600513 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 10187789 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 12935886 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 23006664 | ||
| Pubmed | Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. | 6.03e-05 | 4 | 111 | 2 | 9305844 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 15174099 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 22172670 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPAG1 EPS8L2 EPB41L4B LARP1 ARHGEF16 PPP1R18 PLCB3 HCFC1 VCPIP1 | 8.61e-05 | 565 | 111 | 9 | 25468996 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SPAG1 RHBDF1 EPB41L4B RAB11FIP1 ARHGEF16 NF1 MICAL2 PLCB3 PLXNB1 | 9.08e-05 | 569 | 111 | 9 | 30639242 |
| Pubmed | Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. | 1.00e-04 | 5 | 111 | 2 | 18787130 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 34242819 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 15611108 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 20976309 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 26468229 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 20881122 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 27443384 | ||
| Pubmed | The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. | 1.00e-04 | 5 | 111 | 2 | 15494528 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 19684158 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 37146940 | ||
| Pubmed | PirB functions as an intrinsic suppressor in hippocampal neural stem cells. | 1.00e-04 | 5 | 111 | 2 | 34120891 | |
| Pubmed | PirB regulates a structural substrate for cortical plasticity. | 1.00e-04 | 5 | 111 | 2 | 24302763 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 23927735 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 34437845 | ||
| Pubmed | Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus. | 1.00e-04 | 5 | 111 | 2 | 37147336 | |
| Pubmed | Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. | 1.00e-04 | 5 | 111 | 2 | 33653799 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 21087927 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 20398663 | ||
| Pubmed | Structure and flexibility of the extracellular region of the PirB receptor. | 1.00e-04 | 5 | 111 | 2 | 30674550 | |
| Pubmed | Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. | 1.00e-04 | 5 | 111 | 2 | 23152562 | |
| Pubmed | Regulation of plasmacytoid dendritic cell responses by PIR-B. | 1.00e-04 | 5 | 111 | 2 | 22948046 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 9054430 | ||
| Pubmed | Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. | 1.00e-04 | 5 | 111 | 2 | 10359805 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 27324131 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 10586026 | ||
| Pubmed | Paired immunoglobulin-like receptor B regulates platelet activation. | 1.00e-04 | 5 | 111 | 2 | 25075127 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 11941371 | ||
| Cytoband | 19q13.4 | 1.41e-06 | 79 | 110 | 5 | 19q13.4 | |
| Cytoband | 16p13 | 4.36e-04 | 13 | 110 | 2 | 16p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 6.03e-04 | 1192 | 110 | 10 | chr19q13 | |
| Cytoband | 12q24.2 | 6.68e-04 | 16 | 110 | 2 | 12q24.2 | |
| GeneFamily | Fibronectin type III domain containing | 2.80e-06 | 160 | 70 | 7 | 555 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 1.47e-04 | 5 | 70 | 2 | 1182 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 2.19e-04 | 6 | 70 | 2 | 1181 | |
| GeneFamily | Immunoglobulin like domain containing | 9.08e-04 | 193 | 70 | 5 | 594 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.42e-03 | 19 | 70 | 2 | 832 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.52e-03 | 161 | 70 | 4 | 593 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.18e-03 | 25 | 70 | 2 | 504 | |
| Coexpression | GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 1.06e-06 | 199 | 101 | 8 | M9393 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-08 | 200 | 101 | 8 | fc6aebc20ecaa67606154540a691242dc0aea867 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-08 | 200 | 101 | 8 | 1438b84096de9b4abe9e6213caa07f6bdff67358 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.92e-08 | 162 | 101 | 7 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.92e-08 | 162 | 101 | 7 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.92e-08 | 162 | 101 | 7 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 9.70e-08 | 164 | 101 | 7 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 9.70e-08 | 164 | 101 | 7 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-07 | 179 | 101 | 7 | 06d412fc096d88de168969466ce422f0ab5553b2 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-07 | 189 | 101 | 7 | 984b5f21e84dd8273d8437ac2a5a9de4e9484b9a | |
| ToppCell | Bronchial_Brush-Immune|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.37e-07 | 197 | 101 | 7 | b78d277a1d80ef27c11593ffc68ff8a8abae111f | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.61e-07 | 199 | 101 | 7 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | wk_20-22-Hematologic-Myeloid|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.61e-07 | 199 | 101 | 7 | 0740166c51ce63edf83c4b98fce057f1440116d7 | |
| ToppCell | wk_20-22-Hematologic|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.61e-07 | 199 | 101 | 7 | f360c75e169536578550bed79461a5947e2472b1 | |
| ToppCell | Sigmoid-Macrophage|Sigmoid / Region, Cell class and subclass | 3.73e-07 | 200 | 101 | 7 | b07ac0ff3b8530e99094678fed80f35949cafac8 | |
| ToppCell | Sigmoid-(6)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 3.73e-07 | 200 | 101 | 7 | 9e10cca4429de2c4c8c3c6cf2c9e28637a095be9 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-07 | 200 | 101 | 7 | a1ae299cf77580a6d1a728ee591888b6d70a19d6 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 152 | 101 | 6 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | facs-Heart-RV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 153 | 101 | 6 | af0ae08ff35f8210268457e5e15bcbe5d1f46d67 | |
| ToppCell | facs-Heart-RV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 153 | 101 | 6 | 984a2d847f4376183fdbab7ebc77c1bf7d448f44 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 159 | 101 | 6 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 101 | 6 | cfd005e98944817458e8ef9e0c436d77f50c1ad1 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 101 | 6 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 161 | 101 | 6 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 161 | 101 | 6 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-06 | 172 | 101 | 6 | cf46810dd1072b6f2171e5d9530351ddc79a055b | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.78e-06 | 173 | 101 | 6 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-06 | 175 | 101 | 6 | 92a4a3fd323ee8360edd659f9e16dfddc8788e2f | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-06 | 176 | 101 | 6 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-06 | 180 | 101 | 6 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-06 | 183 | 101 | 6 | b12b89debc9dd6396188bc8fe44f54c01c560966 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-06 | 183 | 101 | 6 | 19cc0009f5332b6e4d4274df123eebbfc80b669a | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-06 | 184 | 101 | 6 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-06 | 185 | 101 | 6 | 00a991e63e9ac6de3f48a96e3be6073f90cbb442 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-06 | 192 | 101 | 6 | 62eac1b8aed4fb924946b58c0237313f697a0136 | |
| ToppCell | (2)_MNPs|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.36e-06 | 194 | 101 | 6 | 9cd64e325ec233da82c463b09262efe93d2a92ee | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.36e-06 | 194 | 101 | 6 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.52e-06 | 195 | 101 | 6 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | 15-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class | 5.52e-06 | 195 | 101 | 6 | 495453b3cf08fa3c5d37ad3a2bf9c526118f9600 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.69e-06 | 196 | 101 | 6 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.69e-06 | 196 | 101 | 6 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | NS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.86e-06 | 197 | 101 | 6 | 496a1115071a1be6928786192de49f3adf197dfb | |
| ToppCell | wk_15-18-Hematologic|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.86e-06 | 197 | 101 | 6 | ecc2f84c1f7442cad668a534e59eccc637dfbf44 | |
| ToppCell | VE-mDC2-|VE / Condition, Cell_class and T cell subcluster | 5.86e-06 | 197 | 101 | 6 | 6629588819ec31a7e4f33b94b8c035145a5f6c17 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-06 | 197 | 101 | 6 | 555ea43eccc3eb22be230c27e13d8b3b64c2a61f | |
| ToppCell | VE-mDC2|VE / Condition, Cell_class and T cell subcluster | 5.86e-06 | 197 | 101 | 6 | e3172102ad17c92c3038cad37bf933eb04351048 | |
| ToppCell | wk_15-18-Hematologic-Myeloid|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.03e-06 | 198 | 101 | 6 | d5a66ed71b0a4b070b19bc3a1540c741865f3cf1 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 6.03e-06 | 198 | 101 | 6 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 6.03e-06 | 198 | 101 | 6 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 6.03e-06 | 198 | 101 | 6 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 6.21e-06 | 199 | 101 | 6 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | BAL-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.21e-06 | 199 | 101 | 6 | 0f0fcc6fb980167cfa9aa404b845441fb95a08f4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.21e-06 | 199 | 101 | 6 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 6.21e-06 | 199 | 101 | 6 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | Mild_COVID-19-Myeloid|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.21e-06 | 199 | 101 | 6 | c0a9f5629db5beff7c07c9d111a7707e062d746f | |
| ToppCell | Caecum-(5)_Dendritic_cell-(50)_cDC2|Caecum / shred on region, Cell_type, and subtype | 6.21e-06 | 199 | 101 | 6 | bf8a10a9db7e8e0a6e2b53747949f442fe0e581e | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 6.21e-06 | 199 | 101 | 6 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 6.21e-06 | 199 | 101 | 6 | 78db2e3b85356ed2f08794e5a97c16a220f8a076 | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 6.21e-06 | 199 | 101 | 6 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.21e-06 | 199 | 101 | 6 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 6.21e-06 | 199 | 101 | 6 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.21e-06 | 199 | 101 | 6 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.21e-06 | 199 | 101 | 6 | a4785c1921a3de18a9190e4d674ede6a90f80004 | |
| ToppCell | Caecum-Dendritic_cell-cDC2|Caecum / Region, Cell class and subclass | 6.21e-06 | 199 | 101 | 6 | 944c567307082dd54dc141e93965d46f4ec8bc1f | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 6.21e-06 | 199 | 101 | 6 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 6.21e-06 | 199 | 101 | 6 | c051cc3e42cfa2ec09fd8dae1172af350bb2dfcb | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | 700960201ae0df2c79e2907f5a0f95d73f8034fe | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | 5ea3e74687893b8ca6cb915f0f14a14d4692775c | |
| ToppCell | Caecum-(4)_Monocyte-(40)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 6.39e-06 | 200 | 101 | 6 | b078058efc51f0ff4d92123b712933b32824c655 | |
| ToppCell | Caecum-(4)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 6.39e-06 | 200 | 101 | 6 | 6bfd6ab395e09087aeedc9a7c9ada1b4b8a26194 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | 7076b0db66c8f90c8f9ccfbc8bc0dcc82b15e5f3 | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 6.39e-06 | 200 | 101 | 6 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | Caecum-Monocyte|Caecum / Region, Cell class and subclass | 6.39e-06 | 200 | 101 | 6 | 9e8d38d024a315512521b349e8ac7caa56219daf | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 6.39e-06 | 200 | 101 | 6 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-06 | 200 | 101 | 6 | 48ce43a27e78b2883e588e1a63fa5352c2deeeb7 | |
| ToppCell | Caecum-Monocyte-Monocyte|Caecum / Region, Cell class and subclass | 6.39e-06 | 200 | 101 | 6 | d33619b6c721eae3ebe50fba6b9d31fa99f2248f | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-cDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 6.39e-06 | 200 | 101 | 6 | d9e6c344c59544c87bc13d1e866491da432c9c1b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.39e-06 | 200 | 101 | 6 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.39e-06 | 200 | 101 | 6 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 147 | 101 | 5 | 684e2d8d2f0516cf8b0dc53efa7efc3050bbf0d1 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 147 | 101 | 5 | c031fad0a4e192019775809968e46da54a111d27 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 149 | 101 | 5 | 23a1b95c12f2e3708dc003e13fab423e89821f11 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 149 | 101 | 5 | c53a3226adc8fd0eaaa842b6a96442287580cbe0 | |
| ToppCell | facs-Skin-nan-18m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 149 | 101 | 5 | bb18a18b891af85849b9658d774053f839c9a8e1 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-05 | 150 | 101 | 5 | b37f538ca5f976b509efe35dc81115b72b227084 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-05 | 150 | 101 | 5 | 2c7518918c40e1bf679a2d4e83b472ee6f2f9df8 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-05 | 152 | 101 | 5 | f717aae4882e9b67e5e40f4ef5b0d35f74a89165 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.57e-05 | 75 | 101 | 4 | 3167beedef7304697e9577270cdeacfc9743cee1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.57e-05 | 75 | 101 | 4 | 70c346f92a9ac7e33fc1b9dee1dca0bf9ae0a38c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.57e-05 | 75 | 101 | 4 | 26d6e54ed0a6c3ff57f6269c460177bc7b8bf979 | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 154 | 101 | 5 | 73de626b210ec5482ba89a65e784c1e77ff2894e | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 154 | 101 | 5 | 56fe9953e58f71626d3ddf63d340ed35dfc4ce9f | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 155 | 101 | 5 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 2.85e-05 | 156 | 101 | 5 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-05 | 157 | 101 | 5 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 158 | 101 | 5 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.03e-05 | 158 | 101 | 5 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.03e-05 | 158 | 101 | 5 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 158 | 101 | 5 | df614450e10629dc9115d7365397663e82f9e48f | |
| Drug | Methocarbamol [532-03-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.77e-06 | 197 | 101 | 8 | 2274_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 3.10e-06 | 200 | 101 | 8 | 3549_UP | |
| Drug | glycerol-3-phosphocholine | 1.18e-05 | 172 | 101 | 7 | CID000000823 | |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.48e-05 | 193 | 101 | 7 | 7181_UP | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 1174_DN | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 4714_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 3531_UP | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 2556_UP | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; HL60; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 3088_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 1299_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 3608_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; HL60; HG-U133A | 3.01e-05 | 199 | 101 | 7 | 1439_DN | |
| Drug | milrinone | 5.60e-05 | 150 | 101 | 6 | CID000004197 | |
| Drug | Tc-99m HMDP | 5.83e-05 | 3 | 101 | 2 | CID000123801 | |
| Drug | alpha-bromo-4-chlorophenylacetic acid | 5.83e-05 | 3 | 101 | 2 | CID010490868 | |
| Drug | l-945 | 5.83e-05 | 3 | 101 | 2 | CID000097919 | |
| Disease | Schwannomatosis, Plexiform | 1.13e-04 | 5 | 100 | 2 | C0751374 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0801767 | |
| Disease | Neurilemmoma | 1.69e-04 | 6 | 100 | 2 | C0027809 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0802705 | |
| Disease | mean arterial pressure, unipolar depression | 1.74e-04 | 32 | 100 | 3 | EFO_0003761, EFO_0006340 | |
| Disease | cathepsin Z measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0008074 | |
| Disease | acid sphingomyelinase-like phosphodiesterase 3a measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0008013 | |
| Disease | hypertension | 6.35e-04 | 307 | 100 | 6 | EFO_0000537 | |
| Disease | juvenile rheumatoid arthritis (is_implicated_in) | 8.66e-04 | 13 | 100 | 2 | DOID:676 (is_implicated_in) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.16e-03 | 15 | 100 | 2 | EFO_0008208 | |
| Disease | susceptibility to cold sores measurement | 1.42e-03 | 65 | 100 | 3 | EFO_0008402 | |
| Disease | visfatin measurement | 1.50e-03 | 17 | 100 | 2 | EFO_0801230 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.68e-03 | 69 | 100 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.77e-03 | 171 | 100 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | Noonan Syndrome | 2.99e-03 | 24 | 100 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APLEPSTLGSKHLPW | 31 | Q96MC4 | |
| IISPVSGPEHPELWR | 216 | O42043 | |
| KIISPVSGPEHPELW | 326 | O71037 | |
| KIVSPVSGPEHPELW | 326 | Q902F8 | |
| IISPVSGPEHPELWR | 326 | Q9UKH3 | |
| KHWKPAEPPTVVTGS | 156 | P33076 | |
| QTGDPVALPHGPEKW | 51 | P0CZ25 | |
| WSIVPEVSEPVEPPK | 276 | Q6IC98 | |
| RPPGHEEPWPIVLST | 61 | Q5VV41 | |
| PPEVWQVLKTHPGDP | 81 | Q9HCU8 | |
| EIDWIPIAHSKPTGG | 391 | Q6P1R3 | |
| LGLEWHLPSPDPVTV | 1621 | Q7Z401 | |
| KIEPPLGWSFEPTTV | 91 | P69849 | |
| KQLAHSVVLAWEPPP | 801 | O95153 | |
| WVKFVPIGAPLDTPT | 171 | Q9BRQ5 | |
| VQAGHLPKPTLWAEP | 21 | Q8N149 | |
| LPKPTLWAEPGSVII | 26 | Q8N149 | |
| VLSGKPPLEGHIPTW | 96 | Q8N8L6 | |
| KSPDGAHLTWEPPSV | 1901 | P51610 | |
| WPTPGEIAHKSVQPQ | 176 | Q6PKG0 | |
| KIEPPLGWSFEPTTV | 91 | Q5JPE7 | |
| PTLWPETEAHVSPPL | 2136 | P78559 | |
| PSHQISPGPTWDIKR | 1276 | Q86UL8 | |
| HPWVTKNGEEPLPSE | 406 | Q8N5S9 | |
| IWTGDSPPHVPVPEL | 106 | Q92484 | |
| EGSWESLPVPLHPQV | 6 | Q8NHQ9 | |
| TDPVSQVVWLPEPGH | 266 | Q96EX3 | |
| AIKTPWPEQHVPVLF | 971 | Q9H6A9 | |
| IRPWHLVKPSDEPEP | 1881 | O43157 | |
| GKEPAPPVAVWKGHS | 886 | O95206 | |
| IEPDPPVSHWKPEAV | 181 | Q96HS1 | |
| IKVIPTPPADHWTLI | 331 | P51160 | |
| GPWLSAAAVIHEPKP | 151 | Q9Y328 | |
| KIEPPLGWSFEPTTV | 91 | Q15155 | |
| PAWRPSGIPEKDLHS | 121 | Q6P1K2 | |
| WPHLSLEPIGELAPV | 1241 | Q86UK5 | |
| THWAEPKSPGVPRDV | 1126 | P09848 | |
| VWSHPSDPLEILPSG | 206 | Q6PI73 | |
| VWSHPSDPLEILPSG | 206 | O75022 | |
| HPGLDQPLIVIWEPS | 286 | Q30201 | |
| LSGKPVLWEPLVHAP | 596 | Q9P1Z3 | |
| KIVSPVSGPEHPELW | 1086 | P63135 | |
| VPKFHSGWEPPVDVL | 416 | Q9H6S3 | |
| WFPHVIQPKPEITAG | 91 | Q8TAX0 | |
| PPPDITWHKDGRAIV | 4106 | Q96RW7 | |
| ALVSWKPPDGPETVV | 836 | Q2VWP7 | |
| WRPIPVHTVPVAEDK | 136 | Q9BZG2 | |
| WKGRPPEEEPFITHG | 366 | Q01970 | |
| AAPWHIPTIALPEGD | 996 | Q711Q0 | |
| HGPVWIESVLPGSPA | 296 | A4D2P6 | |
| IISPVSGPEHPELWR | 216 | P61566 | |
| KIVSPVSGPEHPELW | 326 | P61570 | |
| KIVSPVSGPEHPELW | 326 | Q69384 | |
| IVSPVSGPEHPELWR | 216 | P61567 | |
| FPHVTVAPGWPEEVL | 471 | Q8WW52 | |
| TWPLEVPETEPTLGH | 11 | Q9Y3I1 | |
| APTLSPEHWKAVPPV | 401 | Q96JM3 | |
| PEHWKAVPPVSPELR | 406 | Q96JM3 | |
| PGEDRFKPVVPWPHV | 61 | Q86SF2 | |
| FKPVVPWPHVEGVEV | 66 | Q86SF2 | |
| NSPETKLEPPLWHAE | 1541 | Q8IWJ2 | |
| VDRWPAPVPGKTLHL | 211 | Q8IWF6 | |
| ALHIPPEELSSVPWA | 316 | Q674R7 | |
| IISPVSGPEHPELWR | 326 | P61565 | |
| IISPVSGPEHPELWR | 216 | Q9HDB8 | |
| SAHLWKSPFPDVVPL | 236 | P31276 | |
| KLHPWVTRHGAEPLP | 441 | Q96RR4 | |
| KIISPVSGPEHPELW | 326 | Q902F9 | |
| EGKPLPPHVRIWDSV | 131 | O95834 | |
| EKPILSLHPPWTTIF | 21 | Q6BAA4 | |
| GPVVSLWPAPGKHSE | 271 | Q6UWR7 | |
| GVITTPGIIDSHPWP | 256 | Q6UWW8 | |
| PGIIDSHPWPLAQKI | 261 | Q6UWW8 | |
| VGHEPKKWPISGVLP | 761 | O95479 | |
| EPLAVHTWAPTPQGL | 266 | Q86YV9 | |
| EWPVPGVAPKETAEL | 281 | Q6NYC8 | |
| PPGHLECTPESLWKE | 401 | Q68D06 | |
| LETVKAAGPWPPLHI | 566 | Q9H329 | |
| EEKPWRPGSPHLPHT | 1191 | O94851 | |
| WSLPKDVPAPTVSPH | 1456 | Q9P2P1 | |
| PLVLDPADPTWNVGH | 696 | Q9Y6K5 | |
| KHWAEGVTHPPKPTT | 626 | P22897 | |
| EDVPQGVSPPTWTKI | 3496 | O75445 | |
| KPLLQAWVSPSETHP | 1146 | Q6WKZ4 | |
| PWITPPDLQEKIHIF | 266 | P14373 | |
| WSIPPFPVSGHDIRK | 381 | Q96Q11 | |
| TFESPPPPIEWHISK | 751 | Q07890 | |
| PAPTKPLVLSLHGWT | 81 | Q8N2E6 | |
| VQAGHLPKPTLWAEP | 21 | Q8NHL6 | |
| HVTKDLLWEPATPGP | 51 | Q15572 | |
| PWKPGPHRVFVTQEE | 36 | P08709 | |
| VKWPIHPSAPELAGH | 526 | Q96CC6 | |
| PPPVQVSEKVHAASW | 656 | Q4LDE5 | |
| AQPPHLWKSTLPDVV | 296 | P31271 | |
| PPTWSEFPKGIIVHT | 241 | O95573 | |
| IVDDHTPWVKGSVPP | 246 | O96005 | |
| PDKTTITEPHHIWPT | 1956 | Q6P2Q9 | |
| APHGVSWVKGPLSPE | 206 | Q6ZS11 | |
| SWVKGPLSPEVDHPG | 211 | Q6ZS11 | |
| PAPTKPLVLSLHGWT | 81 | Q5JU69 | |
| EGSSIPWNHLPDPEI | 36 | P17028 | |
| PPSAVPLEPSEHEWL | 301 | Q2M3V2 | |
| PRVPAESGPGWLHKA | 81 | Q8NBB2 | |
| QLTWKHPEALPGPIS | 661 | P35590 | |
| VPASVPLQAWHPAKE | 586 | Q07617 | |
| EKDSPPPEWDSVPVH | 1556 | Q92545 | |
| THWLPVETPEGVPLG | 321 | P30530 | |
| LGPPEHKPVADTHWS | 1546 | P21359 | |
| PILEVPESVTGPWKG | 21 | Q9Y279 | |
| SELHVPPEWLAPGGK | 476 | Q96JH7 | |
| PSWLTPVPDSHKLTD | 376 | Q14997 | |
| WKGKPPDEEPIITHG | 361 | Q00722 | |
| PPKPSLHAWPSSVVE | 26 | Q6UX27 | |
| AHLVPLEEPVPSHWT | 236 | Q9NYA1 | |
| TDLHVQGPPPTVVEW | 391 | Q9UL62 | |
| AKGTPPWTPLSNVHE | 51 | P0C1S8 | |
| HSWKQPEPVSAETPG | 831 | Q5JPB2 | |
| ETGLKPPWHLGVDSL | 411 | Q6BDS2 | |
| KAIGDPSPLIHWVAP | 311 | Q9ULH4 | |
| GITIPPDHKPKSWVA | 996 | Q9NZM1 | |
| TPAKDWTLVETPPGE | 31 | Q00872 |